WWM
CVS icon

Western Wealth Management’s CVS Health CVS Stock Holding History

Western Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
3,509
-4
-0.1% -$357 0.01% 768
2026
Q1 		$252K Sell
3,513
-227
-6% -$17.5K 0.01% 851
2025
Q4 		$297K Buy
3,740
+669
+22% +$52.7K 0.01% 663
2025
Q3 		$232K Sell
3,071
-49
-2% -$3.36K 0.01% 691
2025
Q2 		$215K Sell
3,120
-218
-7% -$14.3K 0.01% 670
2025
Q1 		$226K Buy
+3,338
New +$200K 0.02% 616
2024
Q4 		– Sell
-4,593
Closed -$289K – 761
2024
Q3 		$289K Sell
4,593
-1,614
-26% -$94.2K 0.02% 608
2024
Q2 		$367K Sell
6,207
-11,134
-64% -$696K 0.03% 445
2024
Q1 		$1.38M Sell
17,341
-17,195
-50% -$1.31M 0.11% 179
2023
Q4 		$2.73M Sell
34,536
-2,412
-7% -$172K 0.2% 106
2023
Q3 		$2.58M Buy
36,948
+1,797
+5% +$127K 0.22% 96
2023
Q2 		$2.43M Sell
35,151
-2,440
-6% -$174K 0.21% 105
2023
Q1 		$2.79M Buy
37,591
+77
+0.2% +$6.46K 0.26% 90
2022
Q4 		$3.5M Sell
37,514
-26,714
-42% -$2.58M 0.36% 56
2022
Q3 		$6.12M Buy
64,228
+1,035
+2% +$102K 0.35% 56
2022
Q2 		$5.88M Sell
63,193
-260
-0.4% -$25.4K 0.34% 65
2022
Q1 		$6.42M Buy
63,453
+36,577
+136% +$3.84M 0.31% 68
2021
Q4 		$2.77M Buy
+26,876
New +$2.48M 0.27% 82
2021
Q2 		$3.19M Buy
38,143
+10,534
+38% +$863K 0.33% 66
2021
Q1 		$2.08M Sell
27,609
-4,590
-14% -$334K 0.28% 80
2020
Q4 		$2.2M Buy
32,199
+4,178
+15% +$272K 0.32% 75
2020
Q3 		$1.64M Sell
28,021
-5,563
-17% -$346K 0.27% 94
2020
Q2 		$2.18M Buy
33,584
+71
+0.2% +$4.47K 0.4% 48
2020
Q1 		$1.99M Buy
33,513
+4,509
+16% +$301K 0.46% 48
2019
Q4 		$2.15M Buy
29,004
+279
+1% +$19.6K 0.33% 70
2019
Q3 		$1.82M Sell
28,725
-20,344
-41% -$1.21M 0.38% 60
2019
Q2 		$2.87M Buy
49,069
+23,387
+91% +$1.26M 0.38% 52
2019
Q1 		$1.38M Buy
25,682
+17,071
+198% +$1.05M 0.31% 81
2018
Q4 		$573K Buy
+8,611
New +$643K 0.15% 160

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Western Wealth Management's CVS Position: Q2 2026 in Review

Western Wealth Management reduced its CVS Health (CVS) stake by 0.11% in Q2 2026, selling an estimated $357 and leaving 3,509 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #768.

Western Wealth Management first reported a position in CVS in Q4 2018 and has held it in 29 quarters since. The position peaked at $6.42M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Western Wealth Management held 3,509 shares of CVS Health worth $363K as of Q2 2026.
  • Western Wealth Management sold 4 CVS Health shares in Q2 2026, an estimated $357.
  • CVS Health made up 0.01% of Western Wealth Management's portfolio in Q2 2026, its #768 holding.
  • Western Wealth Management first reported a position in CVS Health in Q4 2018 and has held it in 29 quarters since.
  • Western Wealth Management's CVS Health position peaked at $6.42M in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.